SmartTRAK is excited to be attending LINNC Paris 2018 on June 11-13, 2018, at the Carrousel du Louvre, Paris, France.
Attending the meeting representing SmartTRAK will be Anne Staylor , Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.
The US Spinal Cord Stimulation market reached new heights in Q417/FY17, driven by new products, expanding indications, and a growing demand for non-narcotic alternatives for treating chronic intractable pain.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spinal Cord Stimulation Market Recap and Financial Dashboard.Among the many topics covered in the Q417/FY17 Spinal Cord Stimulation Market Recap are:
SmartTRAK is excited to be attending #ASIPP 2018 - the 20th Annual Meeting of the American Society of Interventional Pain Physicians on March 15-17 at the Marriot Orlando World Center in Orlando, Florida.
The educational events at ASIPP will include practice management, controlled substance management, regenerative medicine, interventional techniques, abstract presentations, a Resident/Fellow section for emergence into practice and much more.
Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at the conference. Please contact us if you would like a meeting.
Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.
A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)
SmartTRAK is excited to be attending #ISC 2018 - International Stroke Conference, January 24-26 at the Los Angeles Convention Center.
The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease.
Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study
Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.)
A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)
SmartTRAK is excited to be attending NANS 2018 - the North American Neuromodulation Society's 21st Annual Meeting meeting on Jan 11-14, 2018 at Caesars Palace in Las Vegas, Nevada.
Fast Growing Spinal Cord Stim Market Slows in Q317
While the overall Neuromodulation Spinal Cord Stimulation (SCS) market continues to see strong, double-digit growth YTD, sequentially the US SCS market decelerated in Q317 due to seasonality and hurricane-related supply chain disruptions, particularly affecting Medtronic.
By Anne Staylor, Managing Editor, SmartTRAK Business Intelligence
YTD, the US SCS market is trending at high growth rates, a faster growth than SmartTRAK’s original 2017 forecast, as next generation products continue to drive unprecedented growth in this highly underpenetrated market. In the US, Abbott, Nevro and Boston Scientific’s (BSX) Q317 YoY SCS revenues increased respectively, while competitive pressures accelerated Medtronic’s US SCS revenue decline, down YoY according to SmartTRAK Financial Dashboard.
Leonardo Kapural, MD discusses interim results from SENZA-CAP in a SmartTRAK interview at ASRA 2017
At the recent American Society of Regional Anesthesia and Pain Medicine (ASRA)
annual meeting in Lake Buena Vista, FL, Leonardo Kapural, MD, professor of anesthesiology at Wake Forest University and principle investigator of the SENZA-RCT, presented interim three month results from SENZA-CAP, a multicenter feasibility study evaluating use of 10 kHz spinal cord stimulation (SCS) for the treatment of chronic abdominal pain (CAP). (See ASRA Poster 4491.)
In an interview at ASRA, SmartTRAK spoke to Dr. Kapural regarding key findings from this study, the addressable market for SCS in chronic abdominal pain, patient engagement as a potential variable, and what’s next for this research.
A transcript of SmartTRAK’s interview with Dr. Kapural is below. Or click on the following video to view the interview recorded live at ASRA 2017. (12:06 minutes.)
Closed-Loop Spinal Cord Stim: The Next Big Thing?
With impressive preliminary data from Saluda Medical’s AVALON trial, and all the big players working on evoked potentials, will closed-loop spinal cord stimulation (#SCS) be the next big thing?
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.